Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shikhar Mehrotra

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Science Advances|March 21, 2025
CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumorIshita Sarkar, Debashree Basak, Puspendu Ghosh, et al.
The Journal of Biological Chemistry|June 15, 2023
A role for microsomal glutathione transferase 1 in melanin biosynthesis and melanoma progressionJie Zhang, Zhi-Wei Ye, Lars Bräutigam, et al.
Cancer Research|August 29, 2014
Promoting thiol expression increases the durability of antitumor T-cell functionsPravin Kesarwani, Amir A Al-Khami, Gina Scurti, et al.
The Journal of Clinical Investigation|May 3, 2019
Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host diseaseM Hanief Sofi, Yongxia Wu, Steven D Schutt, et al.
Cancer Research|April 12, 2018
Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8<sup>+</sup> T CellsC Bryce Johnson, Bennett R May, Brian P Riesenberg, et al.
Cell Reports|May 5, 2021
Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell responseSilvia Vaena, Paramita Chakraborty, Han Gyul Lee, et al.
Breast Cancer Research : BCR|December 4, 2025
Secreted frizzled-related protein 2 monoclonal antibody-mediated IFN-ϒ reprograms tumor-associated macrophages to suppress triple negative breast cancerLillian Hsu, Julie Siegel, Patrick Nasarre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell ResponseShilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, et al.
Cell Reports|July 24, 2024
Alterations of ceramide synthesis induce PD-L1 internalization and signaling to regulate tumor metastasis and immunotherapy responseWyatt Wofford, Jisun Kim, Dosung Kim, et al.
Frontiers in Immunology|December 18, 2020
Antigen Specificity Enhances Disease Control by Tregs in VitiligoZhussipbek Mukhatayev, Emilia R Dellacecca, Cormac Cosgrove, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Science Advances|March 21, 2025
CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumorIshita Sarkar, Debashree Basak, Puspendu Ghosh, et al.
The Journal of Biological Chemistry|June 15, 2023
A role for microsomal glutathione transferase 1 in melanin biosynthesis and melanoma progressionJie Zhang, Zhi-Wei Ye, Lars Bräutigam, et al.
Cancer Research|August 29, 2014
Promoting thiol expression increases the durability of antitumor T-cell functionsPravin Kesarwani, Amir A Al-Khami, Gina Scurti, et al.
The Journal of Clinical Investigation|May 3, 2019
Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host diseaseM Hanief Sofi, Yongxia Wu, Steven D Schutt, et al.
Cancer Research|April 12, 2018
Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8<sup>+</sup> T CellsC Bryce Johnson, Bennett R May, Brian P Riesenberg, et al.
Cell Reports|May 5, 2021
Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell responseSilvia Vaena, Paramita Chakraborty, Han Gyul Lee, et al.
Breast Cancer Research : BCR|December 4, 2025
Secreted frizzled-related protein 2 monoclonal antibody-mediated IFN-ϒ reprograms tumor-associated macrophages to suppress triple negative breast cancerLillian Hsu, Julie Siegel, Patrick Nasarre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell ResponseShilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, et al.
Cell Reports|July 24, 2024
Alterations of ceramide synthesis induce PD-L1 internalization and signaling to regulate tumor metastasis and immunotherapy responseWyatt Wofford, Jisun Kim, Dosung Kim, et al.
Frontiers in Immunology|December 18, 2020
Antigen Specificity Enhances Disease Control by Tregs in VitiligoZhussipbek Mukhatayev, Emilia R Dellacecca, Cormac Cosgrove, et al.
Pageof 12